Medications 8 min read

Belsomra (Suvorexant)

Drug class Dual orexin receptor antagonist (DORA)
Generic Suvorexant
Schedule DEA Schedule IV (low abuse potential)
Half life About 12 hours
Fda year 2014
Typical dose 10mg to 20mg at bedtime

Belsomra (suvorexant) blocks the brain's wake signal instead of forcing sedation. Best for staying asleep, and the dependence math beats the benzos.

Most sleeping pills work by hitting you over the head. Benzos and the Z-drugs (Ambien, Lunesta) crank up GABA, the brain’s main “slow down” chemical, and basically push you toward unconsciousness whether your body was ready or not. Belsomra does something different, and that difference is the whole reason it’s worth talking about. It doesn’t sedate you. It takes its foot off the gas pedal that keeps you awake.

The generic name is suvorexant. The class is a mouthful, dual orexin receptor antagonist, which everybody shortens to DORA. The FDA cleared it back in 2014, so it’s not new, but a lot of guys have never heard of it because it never got the marketing budget Ambien did.[1] If you’ve been white-knuckling your sleep for years and you don’t love the idea of a drug that knocks you flat, this one’s at least a different animal. Whether it’s the right animal for you is the rest of this piece.

What orexin actually is, and why blocking it helps

Orexin (sometimes called hypocretin) is a signal your brain makes to keep you awake and alert. Think of it as the thing that holds the “on” switch down all day. Levels naturally drop at night so you can drift off, and they come back up in the morning. People with narcolepsy are missing orexin almost entirely, which is why they fall asleep mid-sentence. Most of us have the opposite problem at 2am, the switch is still half-on when we want it all the way off.[2]

Suvorexant sits on the orexin receptors and quietly blocks that wake signal. It’s not adding sedation, it’s removing alertness, which sounds like splitting hairs until you’ve felt the difference. The idea is that it lets sleep happen on something closer to your own terms instead of clubbing you. That’s the theory, anyway, and the mechanism here is genuinely well understood, which is more than I can say for half the drugs in psychiatry.

It doesn’t add sleep, it subtracts wakefulness. Sounds like splitting hairs until you’ve felt the difference.

Where this fits the anti-benzo thing

I’m pretty open about not loving benzos for sleep, and the Z-drugs are basically benzos wearing a different hat. The problem with both isn’t that they don’t work, it’s that they work great for a few weeks and then your brain adjusts, so you need more for the same effect, and coming off them can wreck your sleep worse than before you started. That’s the tolerance and dependence spiral, and a lot of guys are quietly stuck in it.

Suvorexant doesn’t seem to do that the same way. Because it’s working on the wake system rather than juicing GABA, the rebound and dependence picture looks a lot gentler in the trials.[3] Now, full honesty, it’s a controlled substance, DEA Schedule IV, same legal tier as the benzos technically. But the abuse-potential studies put it low, and in practice nobody’s crushing suvorexant to get high. The schedule’s more about caution than about it being a party drug.

So if you’re looking at the menu and the only options you’ve been offered are “the addictive ones,” it’s fair to ask your prescriber about this lane instead. Belsomra isn’t the only DORA on the shelf either, Quviviq works on the same orexin system with a shorter half-life. It’s not magic and I’ll get to the downsides, but the dependence math is genuinely better.

Who it’s actually for

Here’s the honest split. Belsomra’s better at keeping you asleep than at knocking you out fast. If your problem is “I lie there for an hour staring at the ceiling,” it’ll help some, but it’s not a fast-acting sledgehammer and it might frustrate you. If your problem is “I fall asleep fine but I’m wide awake at 3am and done for the night,” this is much more its wheelhouse. Sleep maintenance is where it earns its keep.[4]

And before anybody reaches for any pill, the boring stuff actually matters. Most guys who think they’ve got insomnia have a phone in bed, three beers, a 2pm coffee they forgot about, and a bedroom that’s too warm and too bright. Drink water like you actually like it, kill the screens an hour out, keep the room cold and dark. CBT-I, the talk-therapy approach to insomnia, beats every sleeping pill long-term and it’s not close.[5] If you want to see how the actual pills stack up against each other, I’ve ranked the sleep meds by what holds up. A drug like this is for when you’ve squared away the basics and your brain still won’t quit. It supports the fixing, it doesn’t replace it.

A quiet dim bedroom at dawn with soft early light through the curtains
The boring stuff (cold, dark, no screens) does more work than most guys give it credit for.

Starting it and what the first weeks feel like

Dosing runs 10mg to 20mg, taken once, within 30 minutes of getting in bed. The big rule is you need a real sleep window in front of you, at least seven hours before you’ve got to be up and functional. Take it at midnight planning to wake at 5 and you’re going to feel like you’re wading through wet concrete the next morning. That’s not the drug failing, that’s you not giving it room.

Most people start at 10mg and only go up if that’s clearly not cutting it, because the next-day grogginess scales with the dose. The first few nights can feel a little odd, some guys notice it takes a bit to actually drift off even though they feel the alertness draining away. That’s the mechanism doing its thing, it’s pulling the wake signal down rather than slamming a sedation door. Give it a week or two before you decide.

The side effects people actually notice

The big one, by a mile, is next-day drowsiness. If you dosed too high or shorted your sleep window, you’ll feel it, and it’s worse at 20mg than 10mg. Some people get a headache, weird dreams, or dry mouth. None of that’s dramatic, it’s the usual sleeping-pill tax, just generally on the lighter side compared to where a Z-drug can leave you.

Then there’s the genuinely strange stuff, and I’d be a damn liar if I pretended it never happens. Some people get sleep paralysis, that horror-movie thing where you wake up but can’t move for a few seconds. Others get hypnagogic hallucinations, vivid dreamlike images right as they’re falling asleep or waking. It’s tied to the orexin system and the same wiring that goes haywire in narcolepsy, so it makes mechanistic sense, but it’s unsettling the first time. It’s not common, and it’s not dangerous, but you should know it’s on the list so it doesn’t scare the hell out of you at 3am.

The serious-but-rare ones, kept in proportion

Next-day driving impairment is the one the FDA actually flagged, especially at the 20mg dose. The label’s explicit that you can be impaired the morning after even if you feel fine, so if you took 20mg, be honest with yourself about the commute.[6] Lower the dose if mornings are rough rather than toughing it out.

Like other sleep meds, there are rare reports of complex sleep behaviors, doing things while not fully awake (eating, walking, in rare cases driving) with no memory of it. It’s uncommon, but if it ever happens even once, you stop the drug and call your prescriber, no debate. And the standard caution applies, if your low mood includes any thoughts of not wanting to be here, that’s a conversation to have out loud, not something to medicate around the edges of with a sleep aid.

Interactions and caveats worth knowing

Don’t combine it with alcohol. This isn’t the nanny-state version of that warning, it genuinely stacks the sedation and the next-day fog in a way that’s worse than either alone, so the nightcap-plus-pill routine is a bad plan. Same logic for other sedating stuff, opioids, other sleep meds, some allergy pills.

Suvorexant is processed by a liver enzyme (CYP3A) that a lot of other drugs mess with, so certain antifungals, some antibiotics, and even grapefruit juice in quantity can push its levels around. Tell your prescriber everything you’re taking, including the supplements you don’t think count. And then the practical caveat nobody warns you about up front, it’s expensive and insurance loves to make you jump through hoops for it, often demanding you fail a cheaper generic first. Worth knowing before you get your hopes up at the pharmacy counter.

The honest bottom line

I like the concept here a lot more than I like most sleeping pills, and the dependence profile is a real point in its favor, another tick in the not-a-benzo column. The mechanism is clean and well understood, and for the guy who falls asleep fine but can’t stay asleep, it’s a genuinely reasonable option that won’t dig the hole that benzos dig.

That said, I won’t oversell it. The effect sizes in the trials are modest, we’re talking maybe falling asleep a little faster and getting some extra minutes of sleep, not a brand new life.[7] It costs real money, the insurance dance is annoying, and the weird hypnagogic stuff puts some people off. It’s not a fix for a bedroom full of bad habits and a phone you can’t put down. But if you’ve squared away the basics, tried the boring stuff, and your brain still won’t take its foot off the gas at night, this is a sane thing to ask about. Just go in with realistic expectations and a sleep window you’ll actually honor.

Sources

FDA prescribing information for suvorexant (Belsomra) via DailyMed, the source for the dosing, pharmacology, half-life, interaction, and side-effect details in this piece.

Best for
Staying asleep

It shines for sleep maintenance, the 3am wide-awake problem, more than for knocking you out fast at lights-out.

The mechanism
Blocks the wake signal

It blocks orexin, the brain's alertness signal, so it lets sleep happen instead of forcing sedation the way benzos and Z-drugs do.

The honest catch
Modest and pricey

Trial effect sizes are modest, it's expensive, and insurance usually makes you fail a cheaper generic first.

  1. FDA Label U.S. Food and Drug Administration. Belsomra (suvorexant) Prescribing Information. Merck & Co. Initial U.S. approval 2014 (revised).
  2. Nat Rev Neurosci Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nature Reviews Neuroscience. 2007;8(3):171-181.
  3. Int J Clin Pract Citrome L. Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic. International Journal of Clinical Practice. 2014;68(12):1429-1441.
  4. Biol Psychiatry Herring WJ, Connor KM, Ivgy-May N, et al. Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials. Biological Psychiatry. 2016;79(2):136-148.
  5. Ann Intern Med Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine. 2016;165(2):125-133.
  6. FDA Label U.S. Food and Drug Administration. Belsomra (suvorexant) Prescribing Information, Warnings and Precautions 5.1 and Effects on Driving 14.2. Merck & Co. 2014 (revised). Next-day driving impairment observed at 20 mg in a dedicated randomized, placebo-controlled driving study.
  7. PLOS One Kishi T, Matsunaga S, Iwata N. Suvorexant for primary insomnia: a systematic review and meta-analysis of randomized placebo-controlled trials. PLOS One. 2015;10(8):e0136910.